Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2013

01.04.2013 | Gynecologic Oncology

A cross-sectional analysis of lower genital tract intraepithelial neoplasia in immune-compromised women with an abnormal Pap

verfasst von: Wendy Likes, Joseph T. Santoso, Jim Wan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Persistent human papillomavirus (HPV) infections can cause intraepithelial neoplasia of the lower genital tract. Immune-compromised women have higher rates for all lower genital tract intraepithelial neoplasia. We wish to study the distribution of genital intraepithelial neoplasia in women with and without an immune system.

Methods

The study consisted of 343 women with an abnormal genital lesion or cervical cytology who were referred to a gynecologic oncologist. All patients underwent vulva, vaginal, cervical and anal colposcopy. Any lesion detected was biopsied. Demographic and medical data were collected. The Chi-square test was used to determine the relationship between immunosuppression status and various variables, including sites of intraepithelial neoplasia.

Results

Immune-compromised women (N = 33) are more likely than immune-competent women (N = 310) to have intraepithelial neoplasia of the vulva (p < 0.05) and vagina (p < 0.05), but not more likely to have intraepithelial neoplasia of the anus or cervix. Immune-compromised women are more likely than immune-competent women to have multifocal intraepithelial neoplasia (p < 0.001). In addition, immune-compromised women are more likely to have higher grade disease of the vulva and vagina (p < 0.05), and no more likely to have higher grade disease on the cervix or anus than immune-competent women.

Conclusion

Women with conditions suppressing the immune system are at higher risk for HPV-related disease outside of the cervix and for worse HPV-related diseases than immune-competent women. This study highlights the need for vigilant evaluation of the complete lower genital tract in women with immune-compromised systems.
Literatur
1.
Zurück zum Zitat Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N et al (1998) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132(2):277–284PubMedCrossRef Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N et al (1998) The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132(2):277–284PubMedCrossRef
2.
Zurück zum Zitat Kuhn L, Sun XW, Wright TC Jr (1999) Human immunodeficiency virus infection and female lower genital tract malignancy. Curr Opin Obstet Gynecol (Review) 11(1):35–39CrossRef Kuhn L, Sun XW, Wright TC Jr (1999) Human immunodeficiency virus infection and female lower genital tract malignancy. Curr Opin Obstet Gynecol (Review) 11(1):35–39CrossRef
3.
Zurück zum Zitat Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R (1998) A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 178(5):982–986PubMedCrossRef Minkoff H, Feldman J, DeHovitz J, Landesman S, Burk R (1998) A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 178(5):982–986PubMedCrossRef
4.
Zurück zum Zitat Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr (1997) Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337(19):1343–1349 Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr (1997) Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337(19):1343–1349
5.
Zurück zum Zitat Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J (1992) High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 79(3):321–327PubMedCrossRef Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J (1992) High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 79(3):321–327PubMedCrossRef
6.
Zurück zum Zitat Ferenczy A, Coutlee F, Franco E, Hankins C (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ [Review] 169(5):431–434 Ferenczy A, Coutlee F, Franco E, Hankins C (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ [Review] 169(5):431–434
7.
Zurück zum Zitat Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD (1996) Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 87(3):338–344PubMedCrossRef Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD (1996) Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 87(3):338–344PubMedCrossRef
8.
Zurück zum Zitat Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A (1993) Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 82(2):170–174PubMed Maiman M, Fruchter RG, Serur E, Levine PA, Arrastia CD, Sedlis A (1993) Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 82(2):170–174PubMed
9.
Zurück zum Zitat Watts DH, Spino C, Zaborski L, Katzenstein D, Hammer S, Benson C (1999) Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. J Acquir Immune Defic Syndr Hum Retrovirol 20(5):455–462PubMedCrossRef Watts DH, Spino C, Zaborski L, Katzenstein D, Hammer S, Benson C (1999) Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/microl and below 100 cells/microl. J Acquir Immune Defic Syndr Hum Retrovirol 20(5):455–462PubMedCrossRef
10.
Zurück zum Zitat Del Mistro A, Bonaldi L, Bertorelle R, Minucci D, Franzetti M, Cattelan A et al (2001) Genital human papillomavirus types in immunocompetent and immunodepressed women in northeast Italy: prevalence and cytomorphological correlations. J Low Genit Tract Dis 5(1):12–20PubMed Del Mistro A, Bonaldi L, Bertorelle R, Minucci D, Franzetti M, Cattelan A et al (2001) Genital human papillomavirus types in immunocompetent and immunodepressed women in northeast Italy: prevalence and cytomorphological correlations. J Low Genit Tract Dis 5(1):12–20PubMed
11.
Zurück zum Zitat Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD et al (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women’s Interagency HIV Study Group. J Acquir Immune Defic Syndr 21(1):33–41PubMedCrossRef Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD et al (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women’s Interagency HIV Study Group. J Acquir Immune Defic Syndr 21(1):33–41PubMedCrossRef
12.
Zurück zum Zitat Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359(9301):108–113PubMedCrossRef Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359(9301):108–113PubMedCrossRef
13.
Zurück zum Zitat Spitzer M (1999) Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv [Review] 54(2):131–137CrossRef Spitzer M (1999) Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet Gynecol Surv [Review] 54(2):131–137CrossRef
14.
Zurück zum Zitat Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TC Jr (1997) Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 89(5 Pt 1):690–694PubMedCrossRef Chiasson MA, Ellerbrock TV, Bush TJ, Sun XW, Wright TC Jr (1997) Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 89(5 Pt 1):690–694PubMedCrossRef
15.
Zurück zum Zitat Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM et al (2009) Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 23(1):59–70PubMedCrossRef Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM et al (2009) Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 23(1):59–70PubMedCrossRef
16.
Zurück zum Zitat Weis SE, Vecino I, Pogoda JM, Susa JS, Nevoit J, Radaford D et al (2011) Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 54(4):433–441PubMedCrossRef Weis SE, Vecino I, Pogoda JM, Susa JS, Nevoit J, Radaford D et al (2011) Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 54(4):433–441PubMedCrossRef
17.
Zurück zum Zitat Kasiske BL, Snyder JJ, Gilbertson DT, Wang C (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4(6):905–913PubMedCrossRef Kasiske BL, Snyder JJ, Gilbertson DT, Wang C (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4(6):905–913PubMedCrossRef
18.
Zurück zum Zitat Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891–1901PubMedCrossRef Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306(17):1891–1901PubMedCrossRef
19.
Zurück zum Zitat Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581):59–67PubMedCrossRef Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581):59–67PubMedCrossRef
20.
Zurück zum Zitat Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M (2003) High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 295(7):273–279PubMedCrossRef Pfister H, Fuchs PG, Majewski S, Jablonska S, Pniewska I, Malejczyk M (2003) High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 295(7):273–279PubMedCrossRef
21.
Zurück zum Zitat Stoppler MC, Straight SW, Tsao G, Schlegel R, McCance DJ (1996) The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223(1):251–254PubMedCrossRef Stoppler MC, Straight SW, Tsao G, Schlegel R, McCance DJ (1996) The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223(1):251–254PubMedCrossRef
22.
Zurück zum Zitat Yamashita T, Segawa K, Fujinaga Y, Nishikawa T, Fujinaga K (1993) Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene 8(9):2433–2441PubMed Yamashita T, Segawa K, Fujinaga Y, Nishikawa T, Fujinaga K (1993) Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Oncogene 8(9):2433–2441PubMed
23.
Zurück zum Zitat Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH et al (2011) Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol 118(4):831–839PubMedCrossRef Massad LS, Xie X, Darragh T, Minkoff H, Levine AM, Watts DH et al (2011) Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection. Obstet Gynecol 118(4):831–839PubMedCrossRef
Metadaten
Titel
A cross-sectional analysis of lower genital tract intraepithelial neoplasia in immune-compromised women with an abnormal Pap
verfasst von
Wendy Likes
Joseph T. Santoso
Jim Wan
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2637-3

Weitere Artikel der Ausgabe 4/2013

Archives of Gynecology and Obstetrics 4/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.